InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Murray Mark Anthony. Officer active across 2 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 4 disclosures have been published. Activity tracked since 7 June 2021. The latest transaction was filed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations